The CEO who loves AI autodidacts — and desperately needs his experts

Bob Bradway's early investment in AI for biotech company Amgen is paying off, but it's also causing a significant internal shift. Bradway has championed AI autodidacts, individuals who teach themselves about the technology, but Amgen is now struggling to balance these self-taught experts with more traditional scientific experts. This dynamic highlights a broader industry challenge: how to integrate and leverage both types of knowledge to drive innovation while maintaining scientific rigor and expertise. As companies increasingly adopt AI, the role of human expertise in interpreting and guiding AI-driven insights becomes ever more critical.